VIVUS, Inc.
(Other OTC/NBB : VVUS)

( )
VVUS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc. -0.96%27.7614.1%$163.34m
ICLRICON plc 0.51%223.124.2%$141.43m
HZNPHorizon Therapeutics Plc 0.65%89.885.5%$120.33m
JAZZJazz Pharmaceuticals Plc 1.18%172.842.3%$111.24m
CTLTCatalent, Inc. -0.44%106.012.1%$104.15m
GWPHGW Pharmaceuticals Plc 0.00%218.966.1%$99.11m
BHCBausch Health Cos., Inc. -0.96%27.760.0%$84.96m
UTHRUnited Therapeutics Corp. -3.06%192.0714.0%$64.26m
SAVACassava Sciences, Inc. -0.55%41.790.0%$62.81m
BLRXBioLineRx Ltd. 2.67%3.850.9%$50.32m
ARGXargenx SE -3.91%258.280.0%$38.37m
PRGOPerrigo Co. Plc 1.33%42.586.9%$35.84m
SAGESAGE Therapeutics, Inc. 1.79%72.077.6%$35.36m
PCRXPacira Biosciences, Inc. 2.03%63.219.9%$26.65m
AMRNAmarin Corp. Plc -3.40%4.541.5%$25.96m

Company Profile

VIVUS, Inc. is a drug-development company dedicated to the development and commercialization of next-generation therapeutic products addressing obesity, diabetes, sleep apnea and sexual health.